Latest News
As investors rotate toward value, Altria, Bristol Myers Squibb, and American Electric Power stand out as reliable dividend stocks with strong payout growth histories and defensive appeal.
Via MarketBeat · July 27, 2026
AirJoule's deal with Kubota to supply Core water systems boosts its commercialization timeline, with Q3 deployments, analyst Moderate Buy ratings, and rising institutional ownership.
Via MarketBeat · July 27, 2026
Trip.com Group (NASDAQ:TCOM) said it will accept and comply with an administrative penalty decision issued by China’s State Administration for Market Regulation, outlining operational changes that include ending certain delegated distribution programs and continuing changes to its pricing practices.
Via MarketBeat · July 27, 2026
Hope Bancorp (NASDAQ:HOPE) reported higher second-quarter earnings and revenue as net interest margin expanded, loan growth accelerated and the company continued to improve its deposit mix ahead of its planned acquisition of SMBC MANUBANK’s commercial banking unit.
The company reported second-quart
Via MarketBeat · July 27, 2026
China takes aim at memory stock profits, and Micron is the target.
Via The Motley Fool · July 27, 2026
This falling ticker seems ripe for a bullish reversal, but things are still complicated for this recently IPO'd company's shares.
Via The Motley Fool · July 27, 2026
Realty Income has a long history of growing shareholder value.
Via The Motley Fool · July 27, 2026
China is taking aim at memory stock profits, and Sandisk could be the next target.
Via The Motley Fool · July 27, 2026
Intel's improving growth trajectory indicates that the stock can sustain its rally over the next three years.
Via The Motley Fool · July 27, 2026
The electric vehicle stock is now down nearly 40% from its high.
Via The Motley Fool · July 27, 2026
Insider disposed of stock automatically upon RSU vesting to cover tax obligations, retaining substantial equity exposure of 43,216 shares and 15,826 derivative securities.
Via The Motley Fool · July 27, 2026
One member of big tech is sitting out the biggest spending boom in corporate history. Its results say more than its budget does.
Via The Motley Fool · July 27, 2026
Amid intensifying Iran war disruptions and record crack spreads, Valero, Marathon Petroleum, and Phillips 66 shares have surged to all-time highs, backed by strong earnings, buybacks, and dividends.
Via MarketBeat · July 27, 2026
Quantum Computing investors have high hopes, but can the company deliver in 2026?
Via The Motley Fool · July 27, 2026
More Salesforce automation can make a SaaS revenue operation worse. When the CRM treats a signed deal as the finish line, every new flow, alert, dashboard,
Via Talk Markets · July 27, 2026
Procter & Gamble usually isn't an exciting stock -- and that may be the reason to consider it, heading into earnings.
Via The Motley Fool · July 27, 2026
Oil prices plunged after the U.S. and Iran suddenly halted fighting that had resumed in recent weeks.
Via The Motley Fool · July 27, 2026
Disposition follows pre-established Rule 10b5-1 trading plan; executive retains ~757,000 shares worth $208.8 million.
Via The Motley Fool · July 27, 2026
The tech stock is down more than 20% from its high.
Via The Motley Fool · July 27, 2026
Why did the Nasdaq give back all of its morning gains? Blame China's semiconductor surprise.
Via The Motley Fool · July 27, 2026
Memory-chip stocks Micron and SK Hynix fell Monday after Chinese rival CXMT rocketed in its IPO on the Shanghai Stock Exchange.
Via Investor's Business Daily · July 27, 2026
Open roles get expensive long before a salary is paid. In Indianapolis, qualified candidates have options, and employers that move slowly often lose them t
Via Talk Markets · July 27, 2026
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session.chartmill.com
Via Chartmill · July 27, 2026
Maplight Therapeutics (NASDAQ:MPLT) reported that its Phase II ZEPHYR trial of ML-007C-MA met its primary endpoint in schizophrenia, with the twice-daily regimen producing a statistically significant improvement in Positive and Negative Syndrome Scale, or PANSS, total scores versus placebo at five w
Via MarketBeat · July 27, 2026
Coca Cola Femsa (NYSE:KOF) reported second-quarter 2026 volume, revenue and profit growth, supported by record quarterly volumes in Brazil, Colombia and Guatemala, while Mexico continued to contend with an excise-tax increase and softer consumer demand.
Chief Executive Officer Ian Craig said consol
Via MarketBeat · July 27, 2026